AngioDynamics
Builds vascular and oncology devices around atherectomy, thrombectomy, ablation, and access lines.
$15.85
After-hours close−0.01 (−0.06%)
At close$15.86(+0.51%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 92.81%38.36M sharesInsiders 5.73%2.37M sharesOther 1.46%603.6K shares
Shares outstanding 41.33M · Float 36.54M · 88.4% free float
Institutions13F, as of Jun 30, 2026
163 holders · 38.36M shares · 32 new positions · 89 increased · 54 reduced · 15 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 3.80M | 9.20% | +117.3K | Aug 7, 2026 |
| Point72 Asset Management, L.P. | 3.06M | 7.41% | −119.3K | Aug 14, 2026 |
| Systematic Financial Management LP | 2.64M | 6.39% | +186.5K | Aug 14, 2026 |
| Armistice Capital, LLC | 2.20M | 5.32% | +329.0K | Aug 14, 2026 |
| Royce & Associates LP | 1.97M | 4.77% | +440.9K | Aug 14, 2026 |
| Broadfin Holdings LLC | 1.82M | 4.40% | −250.8K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.69M | 4.10% | −32.1K | Aug 13, 2026 |
| Weber Capital Management LLC /Adv | 1.36M | 3.28% | −16.5K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 7.70% | 3.18M | 13G | May 15, 2026 ↗ |
| BlackRock, Inc. | 7.20% | 2.92M | 13G | Apr 17, 2025 ↗ |
| Systematic Financial Management LP | 6.10% | 2.51M | 13G | Feb 10, 2026 ↗ |
| Kevin Kotler | 5.90% | 2.42M | 13G | Feb 9, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| James C. Clemmer | director, officer: President and CEO | 862.4K | 2.09% | Jul 24, 2026 |
| Stephen A. Trowbridge | officer: EVP and CFO | 305.8K | 0.74% | Jul 24, 2026 |
| Howard W. Donnelly | director | 178.9K | 0.43% | Jul 22, 2026 |
| Wesley Johnson | director | 155.4K | 0.38% | Jul 22, 2026 |
| Jan Stern Reed | director | 116.9K | 0.28% | Jul 22, 2026 |
| Eileen O'Shea Auen | director | 116.6K | 0.28% | Jul 22, 2026 |
| Lawrence T. Weiss | officer: SVP, Chief Legal Officer | 112.6K | 0.27% | Jul 22, 2026 |
| Chad Thomas Campbell | officer: SVP/GM, Vascular Access | 108.7K | 0.26% | Jul 24, 2026 |
| Karen A. Licitra | director | 102.3K | 0.25% | Jul 22, 2026 |
| Michael E. Tarnoff | director | 95.3K | 0.23% | Jul 22, 2026 |
3 ten-percent owners hold 580.1K shares by Form 4, outside the officers-and-directors figure above · 40 people have not refiled in the last 18 months (3.41M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 30, 2026 | Warren JR Nighanofficer: SVP Quality and Regulatory | Sale | 23,370 | $14.72 | 64,745 |
| Oct 21, 2025 | Lawrence T. Weissofficer: SVP, Chief Legal Officer | Purchase | 10,000 | $11.81 | 93,597 |
| Oct 13, 2025 | Stephen A. Trowbridgeofficer: EVP and CFO | Purchase | 890 | $11.16 | 256,629 |
| Oct 9, 2025 | James C. Clemmerdirector, officer: President and CEO | Purchase | 10,000 | $11.15 | 882,529 |
CongressHouse and Senate disclosures
Not reported.